The Defense Health Agency (DHA) intends to award a sole source contract to Pacific Rim Pathology Medical Corporation for lab kidney biopsy evaluation services at the Naval Medical Center San Diego (NMCSD). This procurement aims to facilitate prompt diagnostic and treatment decisions for military personnel and their families by providing timely processing and analysis of kidney tissue samples, which cannot be performed in-house. The contract will span a base period from October 1, 2024, to September 30, 2025, with four additional option years, and requires compliance with HIPAA regulations and specific technical certifications for personnel. Interested parties must submit capability statements by 0800 AM Pacific Daylight Time on September 9, 2024, to Jojie N. Urrete at jojie.n.urrete.civ@health.mil.